This systematic study aimed to investigate the short-term response of pancreatic cancer cells to gemcitabine, to explore the role of HAb18G/CD147 in this response and to determine the corresponding molecular mechanism of action. This evidence concerns the gene BSG and familial pancreatic carcinoma.